tirzepatide weight loss vs semaglutide for Treatment Tirzepatide Outperforms Semaglutide in Weight

LDL-C concentration is a key lipid parameter determining cardiovascular risk and a target of lipid-lowering therapy

High-TMAO producers have reduced oral carnitine bioavailability The TMAO productivity of gut microbiota may also present a personalized bioavailability of carnitine supplementation

On February 25, 2025, Eli Lilly introduced a more affordable option through their "Zepbound Self Pay Journey Program." This program allows people to purchase Zepbound directly from LillyDirect Self Pay Pharmacy solutions, bypassing traditional insurance and pharmacy channels

Association of circulating ANGPTL8 levels with renal dysfunction: a case-control study

He said that information could help doctors make more informed decisions when treating patients with GLP-1 medications and treating weight loss in the future